clomipramine

1
Reactions 1406 - 16 Jun 2012 S Clomipramine DRESS syndrome with pulmonary involvement: case report A 47-year-old woman developed DRESS syndrome with pulmonary involvement during treatment with clomipramine [route and frequency not stated]. The woman was hospitalised with cough and dyspnoea. She had been receiving clomipramine 50mg for the last 4 weeks in addition to bromazepam for a depressive syndrome. In addition to her progressive respiratory symptoms, she had experienced asthenia for the last month. Examination revealed a slight fever, a transcutaneous oxygen saturation of 96%, BP 130/80mm Hg, and basal crepitant rales. Lymph node examination revealed multiple centimetric inguinal and cervical adenopathies. A chest x-ray showed retrocardiac alveolar condensation associated with a bilateral hilar enlargement. A thoracic angiography showed multiple bilateral ground glass opacities and septa thickening. A complete blood count indicated hyperleucocytosis and her LDH level was 608 IU/L. A bronchial aspiration culture was inflammatory and revealed eosinophils. The bronchoalveolar lavage revealed intense eosinophilic alveolitis. HHV-6 serology showed slightly positive IgG. Epstein-Barr virus serology was positive for EBV-VCA IgG and EBNA IgG antibodies. Clomipramine was discontinued on the second day of the woman’s hospitalisation. On hospital day 4, she presented with a pruritic vesicular rash for 24 hours. A skin biopsy revealed a perivascular inflammatory infiltrate. The histological appearance was consistent with a drug reaction. The level of polynuclear eosinophils increased and reached 7.11 G/L on day 7. Her hypereosinophilia reduced progressively from hospital day 8 and normalised on day 13. Her chest CT scan was normal 1 month after clomipramine discontinuation. Author comment: We report a case of acute eosinophilic pneumopathy whose originality consists in being part of a DRESS syndrome induced by clomipramine. Gallego J, et al. Clomipramine hypersensitivity with predominantly pulmonary involvement. Revue des Maladies Respiratoires 29: 430-434, No. 3, Mar 2012. Available from: URL: http://dx.doi.org/10.1016/j.rmr.2012.01.006 [French; summarised from a translation] - France 803072160 1 Reactions 16 Jun 2012 No. 1406 0114-9954/10/1406-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: lykhanh

Post on 16-Mar-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clomipramine

Reactions 1406 - 16 Jun 2012

SClomipramine

DRESS syndrome with pulmonary involvement:case report

A 47-year-old woman developed DRESS syndrome withpulmonary involvement during treatment withclomipramine [route and frequency not stated].

The woman was hospitalised with cough and dyspnoea.She had been receiving clomipramine 50mg for the last4 weeks in addition to bromazepam for a depressivesyndrome. In addition to her progressive respiratorysymptoms, she had experienced asthenia for the lastmonth. Examination revealed a slight fever, atranscutaneous oxygen saturation of 96%, BP130/80mm Hg, and basal crepitant rales. Lymph nodeexamination revealed multiple centimetric inguinal andcervical adenopathies. A chest x-ray showed retrocardiacalveolar condensation associated with a bilateral hilarenlargement. A thoracic angiography showed multiplebilateral ground glass opacities and septa thickening. Acomplete blood count indicated hyperleucocytosis and herLDH level was 608 IU/L. A bronchial aspiration culture wasinflammatory and revealed eosinophils. Thebronchoalveolar lavage revealed intense eosinophilicalveolitis. HHV-6 serology showed slightly positive IgG.Epstein-Barr virus serology was positive for EBV-VCA IgGand EBNA IgG antibodies.

Clomipramine was discontinued on the second day ofthe woman’s hospitalisation. On hospital day 4, shepresented with a pruritic vesicular rash for 24 hours. A skinbiopsy revealed a perivascular inflammatory infiltrate. Thehistological appearance was consistent with a drugreaction. The level of polynuclear eosinophils increasedand reached 7.11 G/L on day 7. Her hypereosinophiliareduced progressively from hospital day 8 and normalisedon day 13. Her chest CT scan was normal 1 month afterclomipramine discontinuation.

Author comment: We report a case of acute eosinophilicpneumopathy whose originality consists in being part of aDRESS syndrome induced by clomipramine.Gallego J, et al. Clomipramine hypersensitivity with predominantly pulmonaryinvolvement. Revue des Maladies Respiratoires 29: 430-434, No. 3, Mar 2012.Available from: URL: http://dx.doi.org/10.1016/j.rmr.2012.01.006 [French;summarised from a translation] - France 803072160

1

Reactions 16 Jun 2012 No. 14060114-9954/10/1406-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved